ARR
ARMOUR Residential REIT, Inc.
17.34
1 x 17.33
1 x 17.37
bid
ask
+
0.09
0.49%
09:51 AM
timesize
Ytd-2.01%
1y2.88%
17.27
day range
17.46
13.98
52 week range
19.31
Open17.39Prev Close17.25Low17.27High17.46Mkt Cap2.15B
Vol357.09KAvg Vol3.26MEPS2.49P/E6.96Forward P/E5.78
Beta1.35Short Ratio3.06Inst. Own56.02%Dividend2.88Div Yield16.61
Ex Div Date07-15Earning04-2250-d Avg17.16200-d Avg16.991yr Est18.38

ARR News

ARMOUR Residential REIT, Inc. Confirms July 2026 Common Share and Q3 2026 Series C Preferred Share Dividends
globenewswire.com
ARMOUR Residential REIT, Inc. Confirms July 2026 Common Share and Q3 2026 Series C Preferred Share D

VERO BEACH, Florida, July 01, 2026 (GLOBE NEWSWIRE) -- ARMOUR Residential REIT, Inc. (NYSE: ARR and

ARMOUR Residential REIT, Inc. Announces Guidance for July 2026 Dividend Rate Per Common Share
globenewswire.com
ARMOUR Residential REIT, Inc. Announces Guidance for July 2026 Dividend Rate Per Common Share

VERO BEACH, Florida, June 24, 2026 (GLOBE NEWSWIRE) -- ARMOUR Residential REIT, Inc. (NYSE: ARR and

New Strong Sell Stocks for June 23rd
zacks.com
New Strong Sell Stocks for June 23rd

ARR, AMTB and AMPH have been added to the Zacks Rank #5 (Strong Sell) List on June 23rd, 2026.

Similarweb Secures Multi-Year, Seven-Figure ARR Contracts Worth Approximately $47 Million in Total Contract Value
businesswire.com
Similarweb Secures Multi-Year, Seven-Figure ARR Contracts Worth Approximately $47 Million in Total C

TEL AVIV, Israel--(BUSINESS WIRE)--Similarweb Ltd. (NYSE: SMWB), a leading digital data and analytic

Cellebrite: Stronger Fundamentals Support A Buy Rating
seekingalpha.com
Cellebrite: Stronger Fundamentals Support A Buy Rating

Cellebrite (CLBT) remains a buy as fundamentals strengthen, with FedRAMP High achieved and federal d

OpenAI: Mega IPO Faces Anthropic Claude Mythos Reckoning
seekingalpha.com
OpenAI: Mega IPO Faces Anthropic Claude Mythos Reckoning

OpenAI confidentially filed for IPO amid intensifying competition from Anthropic, which now leads in

Docusign Declines 7.2% Since Beating Q1 Earnings & Revenue Estimates
zacks.com
Docusign Declines 7.2% Since Beating Q1 Earnings & Revenue Estimates

DOCU tops Q1 fiscal 2027 earnings and revenue estimates as IAM adoption accelerates, profitability i

Baron Discovery Fund Q1 2026: Who Moved The Needle
seekingalpha.com
Baron Discovery Fund Q1 2026: Who Moved The Needle

In the first quarter of 2026, Baron Discovery Fund declined 10.65% (Institutional Shares), trailing

Buy 6 June Dividend Power Dogs
seekingalpha.com
Buy 6 June Dividend Power Dogs

Dividend Power strategy targets 35 high-yield, low-valuation stocks, with six 'safer' picks showing

Palo Alto Networks: The Market Is Pricing 2030 At 12x
seekingalpha.com
Palo Alto Networks: The Market Is Pricing 2030 At 12x

Palo Alto Networks is a long-term Buy, supported by 28% organic NGS ARR growth and robust AI-driven

DocuSign Reports Q1 Results: Focus on IAM and Financial Outlook
gurufocus.com
DocuSign Reports Q1 Results: Focus on IAM and Financial Outlook

DocuSign (DOCU) experienced a decline of 5% in trading following its Q1 report for April. While the

Alkami Technology Touts $500M ARR, AI Upside and Bank Demand at Fintech Event
marketbeat.com
Alkami Technology Touts $500M ARR, AI Upside and Bank Demand at Fintech Event

Alkami Technology NASDAQ: ALKT executives outlined the company's growth strategy, financial outlook

RYBREVANT FASPRO™ (amivantamab and hyaluronidase-lpuj) pivotal data show strong and durable responses in advanced head and neck cancer where options remain limited
gurufocus.com
RYBREVANT FASPRO™ (amivantamab and hyaluronidase-lpuj) pivotal data show strong and durable response

RYBREVANT FASPRO™ (amivantamab and hyaluronidase-lpuj) pivotal data show strong and durable respon

RYBREVANT® (amivantamab-vmjw) plus LAZCLUZE® (lazertinib) demonstrates prolonged clinical benefit as a first-line treatment for atypical EGFR-mutated non-small cell lung cancer
gurufocus.com
RYBREVANT® (amivantamab-vmjw) plus LAZCLUZE® (lazertinib) demonstrates prolonged clinical benefit as

RYBREVANTÂ (amivantamab-vmjw) plus LAZCLUZEÂ (lazertinib) demonstrates prolonged clinical benefit as

UiPath Q1 Earnings In Line With Estimates, Revenues Increase Y/Y
zacks.com
UiPath Q1 Earnings In Line With Estimates, Revenues Increase Y/Y

PATH tops Q1 FY27 estimates as AI-driven automation demand boosts ARR growth, enterprise expansion d

MongoDB (MDB) Posts Strong Q1 Earnings Driven by Cloud Adoption and AI Momentum
gurufocus.com
MongoDB (MDB) Posts Strong Q1 Earnings Driven by Cloud Adoption and AI Momentum

MongoDB (MDB) has seen its stock rise following a robust Q1 earnings report, although shares have re

The Smartest AI Money Is Buying Nebius
seekingalpha.com
The Smartest AI Money Is Buying Nebius

Leopold Aschenbrenner disclosed a 5.6% stake after Microsoft, Meta, and Nvidia validated Nebius oper

ARMOUR Residential REIT, Inc. Announces June 2026 Dividend Rate per Common Share
globenewswire.com
ARMOUR Residential REIT, Inc. Announces June 2026 Dividend Rate per Common Share

VERO BEACH, Florida, May 28, 2026 (GLOBE NEWSWIRE) -- ARMOUR Residential REIT, Inc. (NYSE: ARR and A

Palo Alto Networks: Why $6 Billion In ARR Is Just The Beginning
seekingalpha.com
Palo Alto Networks: Why $6 Billion In ARR Is Just The Beginning

Palo Alto Networks, Inc. remains a Strong Buy as new catalysts reinforce my long-term bullish thesis

Glean Surpasses $300M ARR: Unrivaled Enterprise Context Fuels AI Adoption
businesswire.com
Glean Surpasses $300M ARR: Unrivaled Enterprise Context Fuels AI Adoption

MOUNTAIN VIEW, Calif.--(BUSINESS WIRE)--Glean today announced it reached $300 million in annual recu

benzinga.com
UBS Maintains Neutral on ARMOUR Residential REIT, Raises Price Target to $18

UBS analyst Douglas Harter maintains ARMOUR Residential REIT (NYSE:ARR) with a Neutral and raises

benzinga.com
Jones Trading Maintains Buy on ARMOUR Residential REIT, Lowers Price Target to $19

Jones Trading analyst Jason Weaver maintains ARMOUR Residential REIT (NYSE:ARR) with a Buy and lo

ARMOUR Residential REIT Q1 2026 Earnings Call Transcript
benzinga.com
ARMOUR Residential REIT Q1 2026 Earnings Call Transcript

benzinga.com
ARMOUR Residential REIT Q1 Adj. EPS $0.76 Beats $0.74 Estimate, Sales $70.714M Miss $79.986M Estimat

ARMOUR Residential REIT (NYSE:ARR) reported quarterly earnings of $0.76 per share which beat the ana

benzinga.com
ARMOUR Residential REIT Q1 Sales $70.714M Miss $79.986M Estimate

ARMOUR Residential REIT (NYSE:ARR) reported quarterly sales of $70.714 million which missed the anal

Earnings Scheduled For April 22, 2026
benzinga.com
Earnings Scheduled For April 22, 2026

benzinga.com
Jones Trading Maintains Buy on ARMOUR Residential REIT, Lowers Price Target to $20

Jones Trading analyst Jason Weaver maintains ARMOUR Residential REIT (NYSE:ARR) with a Buy and lo

Insights into ARMOUR Residential REIT Q4 Earnings
benzinga.com
Insights into ARMOUR Residential REIT Q4 Earnings

benzinga.com
ARMOUR Residential REIT Q4 Adj. EPS $0.71 Misses $0.78 Estimate, Sales $50.400M Miss $59.099M Estima

ARMOUR Residential REIT (NYSE:ARR) reported quarterly earnings of $0.71 per share which missed the a

Earnings Scheduled For February 18, 2026
benzinga.com
Earnings Scheduled For February 18, 2026

Is the Market Bullish or Bearish on ARMOUR Residential REIT Inc?
benzinga.com
Is the Market Bullish or Bearish on ARMOUR Residential REIT Inc?

What Does the Market Think About ARMOUR Residential REIT Inc?
benzinga.com
What Does the Market Think About ARMOUR Residential REIT Inc?

A Look Into ARMOUR Residential REIT Inc's Price Over Earnings
benzinga.com
A Look Into ARMOUR Residential REIT Inc's Price Over Earnings

benzinga.com
Jones Trading Upgrades ARMOUR Residential REIT to Buy, Announces $20.5 Price Target

Jones Trading analyst Jason Weaver upgrades ARMOUR Residential REIT (NYSE:ARR) from Hold to Buy a

Wall Street's Most Accurate Analysts Weigh In On 3 Financial Stocks With Over 15% Dividend Yields
benzinga.com
Wall Street's Most Accurate Analysts Weigh In On 3 Financial Stocks With Over 15% Dividend Yields

P/E Ratio Insights for ARMOUR Residential REIT
benzinga.com
P/E Ratio Insights for ARMOUR Residential REIT

What Does the Market Think About ARMOUR Residential REIT Inc?
benzinga.com
What Does the Market Think About ARMOUR Residential REIT Inc?

How Is The Market Feeling About ARMOUR Residential REIT Inc?
benzinga.com
How Is The Market Feeling About ARMOUR Residential REIT Inc?

benzinga.com
Compass Point Initiates Coverage On ARMOUR Residential REIT with Buy Rating, Announces Price Target

Compass Point analyst Jason Stewart initiates coverage on ARMOUR Residential REIT (NYSE:ARR) with

benzinga.com
ARMOUR Residential REIT Q3 EPS $0.72, Sales $38.500M Miss $59.366M Estimate

ARMOUR Residential REIT (NYSE:ARR) reported quarterly earnings of $0.72 per share which beat the ana

benzinga.com
Earnings Scheduled For October 22, 2025

benzinga.com
UBS Maintains Neutral on ARMOUR Residential REIT, Lowers Price Target to $15.5

UBS analyst Douglas Harter maintains ARMOUR Residential REIT (NYSE:ARR) with a Neutral and lowers

benzinga.com
Earnings Scheduled For July 23, 2025

benzinga.com
Earnings Scheduled For April 23, 2025

benzinga.com
Earnings Scheduled For February 12, 2025

benzinga.com
Earnings Scheduled For October 25, 2023

Companies Reporting Before The Bell • Deutsche Bank (NYSE:DB) is estimated to report quarterly earn

benzinga.com
Stocks That Hit 52-Week Lows On Tuesday

  On Tuesday, 647 companies set new 52-week lows.

benzinga.com
Stocks That Hit 52-Week Lows On Monday

  On Monday, 369 companies set new 52-week lows.

benzinga.com
Stocks That Hit 52-Week Lows On Thursday

  During Thursday's session, 406 companies made new 52-week lows.

benzinga.com
Stocks That Hit 52-Week Lows On Tuesday

  On Tuesday, 386 stocks made new 52-week lows.